[go: up one dir, main page]

NO911121L - Nye squalensyntetaseinhibitorer - Google Patents

Nye squalensyntetaseinhibitorer

Info

Publication number
NO911121L
NO911121L NO91911121A NO911121A NO911121L NO 911121 L NO911121 L NO 911121L NO 91911121 A NO91911121 A NO 91911121A NO 911121 A NO911121 A NO 911121A NO 911121 L NO911121 L NO 911121L
Authority
NO
Norway
Prior art keywords
squalens
new
synthetase inhibitors
image
synthetase
Prior art date
Application number
NO91911121A
Other languages
English (en)
Other versions
NO911121D0 (no
Inventor
James D Bergstrom
Otto D Hensens
Leeyuan Huang
Jerrold M Liesch
Janet C Onishi
Frank L Vanmiddlesworth
Maria T Diez
Mary Nallin
Fernando Pelaez Perez
Kenneth F Bartizal
Walter Rozdilsky
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/496,742 external-priority patent/US5096923A/en
Priority claimed from US07/626,071 external-priority patent/US5053425A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO911121D0 publication Critical patent/NO911121D0/no
Publication of NO911121L publication Critical patent/NO911121L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Det beskrives forbindelser med struktur-formelen (I):. som er anvendbare for behandling av hyper-kolesterolemi og for inhibering av sopp-vekst.
NO91911121A 1990-03-21 1991-03-20 Nye squalensyntetaseinhibitorer NO911121L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49673190A 1990-03-21 1990-03-21
US49674990A 1990-03-21 1990-03-21
US07/496,742 US5096923A (en) 1990-03-21 1990-03-21 Novel squalene synthetase inhibitors
US07/626,071 US5053425A (en) 1990-03-21 1990-12-11 Novel anti-fungal compounds

Publications (2)

Publication Number Publication Date
NO911121D0 NO911121D0 (no) 1991-03-20
NO911121L true NO911121L (no) 1991-09-23

Family

ID=27504381

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911121A NO911121L (no) 1990-03-21 1991-03-20 Nye squalensyntetaseinhibitorer

Country Status (17)

Country Link
EP (1) EP0450812B1 (no)
JP (1) JPH04279589A (no)
KR (1) KR910016931A (no)
AT (1) ATE104982T1 (no)
AU (1) AU640755B2 (no)
CA (1) CA2038517A1 (no)
CS (1) CS71991A2 (no)
DE (2) DE69101802T2 (no)
DK (1) DK0450812T3 (no)
ES (1) ES2052463T1 (no)
GR (1) GR920300106T1 (no)
HU (1) HUT61555A (no)
IE (1) IE910924A1 (no)
IL (1) IL97535A0 (no)
NO (1) NO911121L (no)
NZ (1) NZ237448A (no)
PT (1) PT97077A (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97251A0 (en) * 1990-03-21 1992-05-25 Merck & Co Inc Antihypercholesterolemic 2,8-dioxabicyclo(3,2,1)octane derivatives,their preparation and pharmaceutical compositions containing them
GB9100437D0 (en) * 1991-01-09 1991-02-20 Glaxo Group Ltd Chemical compounds
GB9105152D0 (en) * 1991-03-12 1991-04-24 Glaxo Group Ltd Chemical compounds
US5506262A (en) * 1991-05-10 1996-04-09 Merck & Co., Inc. Cholesterol lowering compounds
CA2109523A1 (en) * 1991-05-10 1992-11-26 Robert M. Burk Novel cholesterol lowering compounds
US5256689A (en) * 1991-05-10 1993-10-26 Merck & Co., Inc. Cholesterol lowering compounds
US5250424A (en) * 1991-06-14 1993-10-05 Merck & Co., Inc. Processes for preparing novel squalene synthetase inhibitors
US5200342A (en) * 1991-06-14 1993-04-06 Merck & Co., Inc. Squalene synthetase inhibitors and processes therefrom
EP0524671A1 (en) * 1991-06-27 1993-01-27 Merck & Co. Inc. Novel culture of exserohilum rostratum and processes therefrom
EP0524677A1 (en) * 1991-07-16 1993-01-27 Glaxo Group Limited Cyclic ketal derivatives
US5468771A (en) * 1991-08-07 1995-11-21 Merck & Co., Inc. Cholesterol lowering compound
GB9121380D0 (en) * 1991-10-08 1991-11-20 Glaxo Group Ltd Chemical compounds
GB2261374A (en) * 1991-11-15 1993-05-19 Merck & Co Inc Inhibitors of farnesyl protein transferase as anti-cancer agents
US5294627A (en) * 1992-08-27 1994-03-15 Merck & Co., Inc. Directed biosynthesis of biologically active compounds
US5252471A (en) * 1992-03-09 1993-10-12 Merck & Co., Inc. Directed biosynthesis of cholesterol lowering compounds
WO1993017557A1 (en) * 1992-03-09 1993-09-16 Merck & Co., Inc. Cholesterol lowering compounds produced by directed biosynthesis
GB9205140D0 (en) * 1992-03-10 1992-04-22 Glaxo Group Ltd Chemical compounds
GB9205136D0 (en) * 1992-03-10 1992-04-22 Glaxo Group Ltd Chemical compounds
EP0568946A1 (en) * 1992-05-08 1993-11-10 Takeda Chemical Industries, Ltd. Compound TAN-1607A, its derivatives, their production, and use thereof
US5260215A (en) * 1992-07-20 1993-11-09 Merck & Co., Inc. Fungal microorganism ATCC 74167 capable of producing cholesterol lowering compounds
US5283256A (en) * 1992-07-22 1994-02-01 Merck & Co., Inc. Cholesterol-lowering agents
US5322855A (en) * 1992-10-19 1994-06-21 Merck & Co., Inc. Cholesterol lowering compounds
US5447717A (en) * 1993-02-25 1995-09-05 Merck & Co., Inc. Cholesterol-lowering agents
US5430055A (en) * 1994-04-08 1995-07-04 Pfizer Inc. Inhibitor of squalene synthase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276216A (en) * 1980-07-31 1981-06-30 Ortho Pharmaceutical Corporation Synthesis of dioxabicyclo[3.2.1]octanes and oxepanes
IL97251A0 (en) * 1990-03-21 1992-05-25 Merck & Co Inc Antihypercholesterolemic 2,8-dioxabicyclo(3,2,1)octane derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK0450812T3 (da) 1994-06-06
DE69101802T2 (de) 1994-10-27
HUT61555A (en) 1993-01-28
IE910924A1 (en) 1991-09-25
GR920300106T1 (en) 1993-02-17
CA2038517A1 (en) 1991-09-22
ATE104982T1 (de) 1994-05-15
AU7368391A (en) 1993-01-28
JPH04279589A (ja) 1992-10-05
NZ237448A (en) 1993-11-25
DE69101802D1 (de) 1994-06-01
AU640755B2 (en) 1993-09-02
HU910930D0 (en) 1991-10-28
ES2052463T1 (es) 1994-07-16
EP0450812A1 (en) 1991-10-09
KR910016931A (ko) 1991-11-05
EP0450812B1 (en) 1994-04-27
CS71991A2 (en) 1991-11-12
PT97077A (pt) 1991-11-29
DE450812T1 (de) 1992-11-26
IL97535A0 (en) 1992-06-21
NO911121D0 (no) 1991-03-20

Similar Documents

Publication Publication Date Title
NO911121L (no) Nye squalensyntetaseinhibitorer
ES2128092T3 (es) Derivados de anilina.
DK0589924T3 (da) Fluoralkoxybenzylaminoderivater af nitrogenholdige heterocyclusser
DE122007000045I1 (de) Hydroxyethylaminosulfonamide verwendbar als Inhibitoren retroviraler Proteasen
DK0468012T3 (da) 17beta-substituerede 4-aza-5alfa-androstan-3-on-derivater og fremgangsmåde til fremstilling deraf
NO934718L (no) Nye HIV protease inhibitorer
DK0577040T3 (da) Fremgangsmåde til fremstilling af (3R,5S)6-hydroxy-3,,5-O-isopropyliden-3,5-dihydroxyhexansyre-tert.-butylester
ATE135344T1 (de) Aromatische ester von phenylendialkanoaten als inhibitoren humaner neutrophiler elastase
DK0604186T3 (da) HIV-proteaseinhibitorer, som er egnede til behandling af AIDS
DE69528978D1 (de) Lactamverbindungen als Inhibitoren der Cholesterin-Esterase
NO306297B1 (no) FremgangsmÕte for fremstilling av HIV-proteaseinhibitorer
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.
ES2132245T3 (es) Derivados de 1-azaadamantano como agonistas o antagonistas de 5-ht.
DE69025817D1 (de) 3-Keto-HMG-CoA Reduktase-Inhibitoren
EA199800931A1 (ru) Способ получения ингибиторов фосфодиэстеразы iv